House Bill No. 14 proposes amendments to the Uniform Controlled Dangerous Substances Law in Louisiana by adding Mitragynine and 7-Hydroxy-mitragynine to Schedule I. The bill enacts new legal language under R.S. 40:964(Schedule I)(G), which categorizes these substances as controlled dangerous substances unless they are specifically exempted or included in an FDA-approved pharmaceutical product. This addition reflects a shift in the legal status of these substances, recognizing their potential for abuse and addiction.

Additionally, the bill repeals existing provisions related to the unlawful distribution of products containing Mitragyna speciosa to minors, as well as Act No. 231 from the 2019 Regular Session, which previously conditioned the classification of Mitragyna on federal Drug Enforcement Administration actions. By removing these provisions, the bill simplifies the legal framework surrounding these substances and establishes a clear classification under state law.

Statutes affected:
HB14 Original:
HB14 Engrossed: